On July 1, 2009, the municipal government of Dalian, Liaoning province, China approved the development project of Pegasus BioPark (Dalian) Co., Ltd. The BioPark site will be along the seashore of Zhuanghe City under the jurisdiction of Dalian, which is on the north shore of the Yellow Sea between the cities of Dalian and Dandong. The municipal government had provided 1.074968 million square meters of land, in which 240,000 square meters are approved for building plants and 250,000 square meters are for living area. The production zone will produce and supply a series of Active Pharmaceutical Ingredients (API), pharmaceuticals and healthcare products for botanical small molecule drugs, peptides (protein fragments) drugs, and peptide vaccines in global market.